CSF2RA OVEREXPRESSION Detail (hg19) (CSF2RA)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chrX|Y:1,337,693-1,429,274 |
| hg38 |
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
| Type | Database | ID | Link |
|---|---|---|---|
| Gene | MIM | ||
| HGNC | |||
| Ensembl | |||
| NCBI | |||
| Gene Cards | |||
| OncoKB |
| Type | Database | ID | Link |
|---|---|---|---|
| Variant | TogoVar | ||
| COSMIC | |||
| MONDO |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| Adjuvant setting. GM-CSF is not helpful as an immune adjuvant in this dose and schedule and raise co... | MMMP | Detail |
| A phase II trial demonstrated that combining oxaliplatin + docetaxel + GM-CSF yields no objective tu... | MMMP | Detail |
| In this non-comparative phase II clinical trial of a GMCSF-encoding oncolytic herpesvirus, promising... | MMMP | Detail |
- Gene
- -
- Genome
- hg19
- Position
- chrX|Y:1,337,693-1,429,274
- Variant Type
- cnv
Genome browser